GET CERTIFIED IN DRUG SAFETY


RECOGNIZED COURSE QUALITY


DESIGNED FOR EXPERTS BY EXPERTS


ROLE OF BENEFIT-RISK ASSESSMENT AND PHARMACOECONOMICS IN DECISION-MAKING OF MEDICINES


OBJECTIVES

This course gives you an introduction about the role of benefit-risk assessment and pharmacoeconomics in decision-making of medicines.

It provides insight in the changing health care environment and gives an overview of the different stakeholders that are involved in pharmacotherapeutic decision-making. Specific attention is given to the drivers and background of the different stakeholders and the rationale of benefit/risk and pharmacoeconomic evaluations in decision-making.

BR Assessment, BR framework, Decision Making, Pharmacoeco

 

LEARNING OUTCOMES

At the end of this course, you will:

  •  have insight in the changing healthcare environment

  •  be able to delineate the process of decision-making

  •  be able to explain the rationale of benefit-risk and pharmacoeconomic evaluation

  •  know the different stakeholders involved in the process of decision-making and be aware of the differences between key drivers of stakeholders

  •  be able to examine and demonstrate the viewpoint of a stakeholder in an example case

 

120 minutes
Online based learning
English language
Certificate of Achievement
200 €
REGISTER NOW

AUTHORS

avatar

Prof. Olaf Klungel

Utrecht Universiteit

avatar

Prof. Jan A.m. Raaijmakers

GlaxoSmithKline Research and Development Ltd


avatar

Prof. Hubert Leufkens

Utrecht Universiteit

avatar

Dr. George Quartey

F. Hoffmann-La Roche Ltd




COMPANIES OFFER

Short courses can be included in a training package for your team!


NEED TO TALK TO US?

+33 5 47 30 42 69

Monday-Friday / 9.00am-6.00pm CET

 

Supported By

IMI logo EU logo efpia logo

Created By

Eu2P Partners